跳至主要内容
临床试验/NCT07070492
NCT07070492尚未招募不适用

Outcomes of Combined Cataract Surgery With Retinal Surgery for Visually Significant Epiretinal Membrane With Vivity Versus Monofocal Intraocular Lens

Debbie Kuo, MD0 个研究点目标入组 36 人开始时间: 2025年7月1日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
尚未招募
发起方
入组人数
36
主要终点
Vision Acuity

研究概览

简要总结

To investigate the patient Quality of Life and satisfaction outcomes of combined cataract surgery with retinal surgery for visually significant epiretinal membrane in patients receiving Vivity IOL versus standard monofocal controls.

详细描述

The information gained by this study will help understand better the suitability of Vivity IOLs for patients with a common retinal condition and potentially expand access and offering of premium IOLs to help patients gain independence from glasses, which can improve quality of life.

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •Adult patients with visually significant epiretinal membrane who are undergoing or have already had pars plana vitrectomy and membrane peel combined with cataract surgery using Clareon Vivity and Clareon Vivity Toric IOLs or monofocal IOL
  • •IOL powers between +6D to +30.0D, T3-T6

排除标准

  • •History of ocular or refractive surgery
  • •Other ocular or systemic comorbidities that may alter or reduce visual acuity and contrast sensitivity, such as severe dry eye/ocular surface disease, glaucoma, macular degeneration, retinopathy, neuro-ophthalmic diseases, strabismus/amblyopia etc.
  • •Patients with irregular astigmatism, corneal dystrophies, pupil abnormalities, zonular laxity
  • •Intraoperative or postoperative complications

研究组 & 干预措施

Vivity Extended Depth of Focus IOL

Experimental

干预措施: cataract surgery (Device)

Vivity Extended Depth of Focus IOL

Experimental

干预措施: retinal surgery (Procedure)

Standard monofocal IOL

Active Comparator

干预措施: cataract surgery (Device)

Standard monofocal IOL

Active Comparator

干预措施: retinal surgery (Procedure)

结局指标

主要结局

Vision Acuity

时间窗: At the study visit at least 3 months after the combined cataract and retinal surgeries

次要结局

  • Contrast Sensitivity(At the study visit at least 3 months after the combined cataract and retinal surgeries)
  • Patient Reported Outcomes (PRO) on vision-related Quality of Life (QOL) and satisfaction(At the study visit at least 3 months after the combined cataract and retinal surgeries)

研究者

发起方
Debbie Kuo, MD
申办方类型
Other
责任方
Sponsor Investigator
主要研究者

Debbie Kuo, MD

Palo Alto Foundation Medical Group affiliated Ophthalmologist

Sutter Health

相似试验